A 24-week study to evaluate the efficacy and safety of once-weekly dulaglutide added on to glimepiride in type 2 diabetes (AWARD-8).
about
Dulaglutide in the treatment of adult type 2 diabetes: a perspective for primary care providers.Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes.Effect of once-weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c.Dulaglutide 1.5 mg as an add-on option for patients uncontrolled on insulin: Subgroup analysis by age, duration of diabetes and baseline glycated haemoglobin concentration.Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data.Are peptide conjugates the golden therapy against obesity?Comparison of antidiabetic drugs added to sulfonylurea monotherapy in patients with type 2 diabetes mellitus: A network meta-analysis
P2860
Q38917672-C235A42C-7961-4E5E-967F-0D9C7BC2805DQ41184651-3E503870-7967-4D8A-B50A-5CA584655D34Q48222857-D6633917-DDFD-4774-BB79-3874BA372291Q50071123-D0DF109E-3667-4B45-80B6-7DD289B79D14Q55345557-511DE255-A317-4B1C-A4DB-D2A86EF8A834Q55427238-8C7C0ADA-A9F9-4652-B34B-FA1BAD6CB149Q58701706-7B9F3713-A296-478E-9A08-496BFAEF3826
P2860
A 24-week study to evaluate the efficacy and safety of once-weekly dulaglutide added on to glimepiride in type 2 diabetes (AWARD-8).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A 24-week study to evaluate th ...... in type 2 diabetes (AWARD-8).
@en
A 24-week study to evaluate th ...... glimepiride in type 2 diabetes
@nl
type
label
A 24-week study to evaluate th ...... in type 2 diabetes (AWARD-8).
@en
A 24-week study to evaluate th ...... glimepiride in type 2 diabetes
@nl
prefLabel
A 24-week study to evaluate th ...... in type 2 diabetes (AWARD-8).
@en
A 24-week study to evaluate th ...... glimepiride in type 2 diabetes
@nl
P2093
P2860
P356
P1476
A 24-week study to evaluate th ...... in type 2 diabetes (AWARD-8).
@en
P2093
E Pintilei
F Perez Manghi
J L Fahrbach
K E Robertson
K M Dungan
R Weitgasser
P2860
P304
P356
10.1111/DOM.12634
P577
2016-01-22T00:00:00Z